Brief: Cosmo Pharmaceuticals Expands Agreement With Dr. Falk Pharma For Rifamycin SV MMX

Cosmo NV

19/11/2020 06:04

Nov 19 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * ANNOUNCES EXPANSION OF AGREEMENT WITH DR. FALK PHARMA FOR
RIFAMYCIN SV MMX
    * COSMO PHARMACEUTICALS - COSMO WILL RECEIVE A FURTHER EUR
2M
DOWN-PAYMENT PLUS REIMBURSEMENT OF A PORTION OF EXPENSES BORNE
FOR DEVELOPMENT OF 600MG FORMULATION PLUS A SUPPLY PRICE WHICH
INCORPORATES A HIGH DOUBLE-DIGIT PERCENTAGE OF SALES
    * DR. FALK WILL ALSO BEAR A PORTION OF FUTURE COSTS FOR
ONGOING
DEVELOPMENTS.

Source text for Eikon:  ID:nTENp9amia 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))